Synchrony Financial (NYSE:SYF)
Synchrony Financial (NYSE:SYF) - For nearly 30 years, CareCredit, from Synchrony Financial (NYSE: SYF), has assisted millions of patients receive needed and desired care. CareCredit is a health, wellness and beauty credit card that can be used as a financing option at more than 185,000 healthcare practices nationwide.
CareCredit, a leading provider of patient financing, and New Look Now, an innovator of “before and after” cosmetic treatment simulations, recently declared they have signed a marketing agreement. The agreement extends the awareness of the CareCredit health, wellness and beauty credit card for beauty-minded consumers who use New Look Now’s treatment visualizer to better understand their aesthetic options and book treatment consultations.
Endorsed by the American Society of Plastic Surgeons, New Look Now has accomplished 50,000+ simulations to date. Under the agreement, New Look Now consumers can apply for the CareCredit health, wellness and beauty credit card while reviewing their New Look Now treatment simulations online, during their practice visit, at an in-practice patient event, or when requesting an appointment with a provider. Consumers can access New Look Now’s visualizer from the comfort and privacy of their own home before ever visiting a doctor’s office.
“The agreement with New Look Now allows us to better serve both consumers and providers by presenting popular financing options during the critical online research and decision-making phases, while offering providers who use the platform a seamless way to integrate CareCredit,” said Greg Pierce, senior vice president, CareCredit.
Synchrony Financial operates as a consumer financial services company in the United States. The company offers private label credit cards, dual cards, and small and medium-sized business credit products; and promotional financing for consumer purchases, such as private label credit cards and installment loans.
Sally Beauty Holdings, Inc. (NYSE:SBH)
On Thursday, Sally Beauty Holdings, Inc. (NYSE:SBH)’s shares inclined 10.31% to $24.40.
SBH has the market capitalization of $3.48 billion. The EPS was $1.50. Institutional ownership of the company was 91.80% while 157.27 million shares were outstanding. Net profit margin of the Company was 49.60% while its gross profit margin was 6.30%. Share of the company moved above its SMA 50 with 0.94%. ROE ratio was -91.40% while ROI was 24.70%.
The mean estimate for the short term price target for Sally Beauty Holdings, Inc. (NYSE:SBH) stands at $29.25 according to 12 Analysts. The higher price target estimate for the stock has been calculated at $34.00 while the lower price target estimate is at $24.00.
Analysts mean recommendation for the stock is 2.60. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Sally Beauty Holdings, Inc. (Sally Beauty) is a retailer and distributor of beauty supplies. The Company operates in North America, South America and Europe. Sally Beauty operates through two business segments namely Sally Beauty Supply and Beauty Systems Group (BSG).
Macy’s, Inc. (NYSE:M)
Macy’s, Inc. (NYSE:M)’s shares gained 0.95% to $40.83.
M has market capitalization of $13.29 billion. Its current ratio was 1.50 while its shares were below its 50 days simple moving average with -21.58%. The company offered earning per share of $4.06 while its 330.98 million shares were outstanding. YTD performance of the company was -37.9%. Stock volatility for the week was 5.10% while for the month it was shown at 3.16%.
The mean estimate for the short term price target for Macy’s, Inc. (NYSE:M) stands at $55 according to 20 Analysts. The higher price target estimate for the stock has been calculated at $72.00 while the lower price target estimate is at $38.00.
Analysts mean recommendation for the stock is 2.70. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Macy’s, Inc. is an omnichannel retail company operating stores, Websites (macys.com, bloomingdales.com and bluemercury.com) and mobile. As of January 31, 2015, the operations of the Company included 823 stores with an area of approximately 147,400,000 square feet in 45 states of the United States, the District of Columbia, Guam and Puerto Rico.
T-Mobile US Inc (NASDAQ:TMUS)
At the end of Thursday’s trade, T-Mobile US Inc (NASDAQ:TMUS)‘s shares surged 1.52% to $37.97.
TMUS Its past 5-day performance at 0.21%. So far in 2015, the company has a year-to-date performance of 40.94%. The stock, as of last close, traded 56.51% up from its 52 week low and was -12.57% below its 52 week high. Its latest closing price was 2.97% above the SMA200 while the distance from SMA 50 and SMA 20 was -5.39% and -3.48% respectively.
The mean estimate for the short term price target for T-Mobile US Inc (NASDAQ:TMUS) stands at $47.74 according to 23 Analysts. The higher price target estimate for the stock has been calculated at $80.00 while the lower price target estimate is at $40.00.
Analysts mean recommendation for the stock is 2.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
T-Mobile US, Inc., together with its subsidiaries, provides mobile communications services in the United States, Puerto Rico, and the U.S. Virgin Islands. The company offers voice, messaging, and data services in the postpaid, prepaid, and wholesale markets.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.